Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Placebo-controlled Phase IIa Study of Orally Administered BGC20-0134/Pleneva TM (Structured Lipid) in Patients With RRMS

NCT01037907 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.

NCT NCT01037907
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01037907 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Placebo-controlled Phase IIa Study of Orally Administered BGC20-0134/Pleneva TM (Structured Lipid) in Patients With RRMS
Lead sponsor
Boston Scientific Corporation
Phase
Phase 2
Overall status
Terminated
Start date
November 30, 2009
Completion date
December 31, 2011
Enrollment
173 (actual)
Sites
35

Conditions

As the registry lists them; a condition with its own page is linked.

relapsing remitting multiple sclerosis